Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Nicoletta Villivà"'
Autor:
Alessia Campagna, Daniela De Benedittis, Luana Fianchi, Emilia Scalzulli, Lorenzo Rizzo, Pasquale Niscola, Anna Lina Piccioni, Ambra Di Veroli, Stefano Mancini, Nicoletta Villivà, Tiziano Martini, Sara Mohamed, Ida Carmosino, Marianna Criscuolo, Susanna Fenu, Maria Antonietta Aloe Spiriti, Francesco Buccisano, Marco Mancini, Agostino Tafuri, Massimo Breccia, Antonella Poloni, Roberto Latagliata
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 9; Pages: 2596
Aims: To define the peculiar features of patients with the deletion of the chromosome 20 long arm (del20q), data from 69 patients with myelodysplastic syndromes (MDSs) and isolated del20q, followed by the Gruppo Romano-Laziale Sindromi Mielodisplasti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9a88e1ea2fd6a6984a75d91dc52d08d
https://pubmed.ncbi.nlm.nih.gov/35566719
https://pubmed.ncbi.nlm.nih.gov/35566719
Autor:
Enrico Montefusco, Laura Scaramucci, Michele Cedrone, Antonio Spadea, Raffaele Porrini, Francesca Spirito, Giuseppe Cimino, Massimo Breccia, Angela Rago, Nicoletta Villivà, Marco Montanaro, Roberto Latagliata, Francesca Paoloni, Ermina Baldacci, Cristina Santoro, Ambra Di Veroli, Barbara Anaclerico, Alessandro Andriani, Maria Gabriella Mazzucconi
Publikováno v:
European Journal of Haematology. 105:335-343
Background and aims Anagrelide is a drug effective in reducing platelet counts in essential thrombocythemia (ET) and Ph1-negative myeloproliferative neoplasms. The aim of this study was to evaluate the real-life use of anagrelide in patients with ET
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ee7f23f3a9332043a0a1ee875fa0aa0
https://doi.org/10.1111/ejh.13454
https://doi.org/10.1111/ejh.13454
Autor:
Daniela Drandi, Catello Califano, Carola Boccomini, Monica Tani, Simone Ferrero, Michele Merli, Pellegrino Musto, Marzia Varettoni, Paolo Casula, Gerardo Musuraca, Maria Giuseppina Cabras, Federica Cavallo, Anna Lia Molinari, Anna Ines Gregorini, Annarita Conconi, Nicoletta Villivà, Lorella Orsucci, Anna Castiglione, Gianluca Gaidano, Martina Ferrante, Stefano Felici, Giulia Benevolo, Donato Mannina, Federico Monaco, Umberto Vitolo, Roberto Sartori
Publikováno v:
Blood. 138:48-48
Introduction Symptomatic patients with relapsed/refractory Waldenström Macroglobulinemia (RR-WM) treated with standard rituximab plus chemotherapy as second-line salvage therapy, generally show a 18-months progression free survival (PFS) of about 50
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::16c6eb55e206a74ec5e5f09cf6578112
https://doi.org/10.1182/blood-2021-148424
https://doi.org/10.1182/blood-2021-148424
Autor:
Antonia Centra, Pasquale Niscola, Massimo Breccia, Luana Fianchi, Elena Maria Elli, Barbara Anaclerico, Roberto Latagliata, Roberto Foa, Ida Carmosino, Andrea Aroldi, Ambra Di Veroli, Nicoletta Villivà, Alessandro Andriani, Vincenza Martini, Guido Montanaro, Giulio Trapè, Maria Teresa Voso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d86e81f7eec0019e78cef2333032f245
https://doi.org/10.1002/hon.2635/v2/response1
https://doi.org/10.1002/hon.2635/v2/response1
Autor:
Pasquale Niscola, Giulio Trapè, Luana Fianchi, Antonia Centra, Roberto Latagliata, Ambra Di Veroli, Elena Maria Elli, Andrea Aroldi, Marco Montanaro, Guido Montanaro, Vincenza Martini, Barbara Anaclerico, Nicoletta Villivà, Ida Carmosino, Alessandro Andriani, Roberto Foa, Massimo Breccia, Maria Teresa Voso
There have been some reports on a possible role of azacytidine (AZA) in the treatment of accelerated/blastic phase evolved from Philadelphia-negative myeloproliferative neoplasms (MPN-AP/BP), but results are conflicting. In this study, we analyzed a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87c02be63e2bcd12fb9a089098afd4b3
http://hdl.handle.net/10281/278730
http://hdl.handle.net/10281/278730
Autor:
Antonio Spadea, Raffaele Porrini, Ambra Di Veroli, Nicola Polverelli, Sabrina Crescenzi Leonetti, Marianna De Muro, Francesca Spirito, Nicoletta Villivà, Cristina Santoro, Angela Rago, Massimo Breccia, Enrico Montefusco, Barbara Anaclerico, Roberto Latagliata, Marco Montanaro, Giuseppe Cimino, Ignazio Majolino, Giuliana Alimena, Maria Gabriella Mazzucconi, Nicola Vianelli, Alessandro Andriani, Francesca Palandri, Cinzia De Gregoris
Publikováno v:
American Journal of Hematology. 91:318-321
Spleen enlargement, present in 10-20% of Essential Thrombocythemia (ET) patients at diagnosis, is a feature clinically easy to assess, confirmable by echography with a very low chance of misinterpretation. Nonetheless, the clinical and prognostic rol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::507e79c50fd62205f03d43a746236a99
https://doi.org/10.1002/ajh.24269
https://doi.org/10.1002/ajh.24269
Autor:
Marco Montanaro, Antonio Spadea, Francesca Spirito, Ignazio Majolino, Jonny Di Giandomenico, Maria Gabriella Mazzucconi, Angela Rago, Raffaele Porrini, Massimo Breccia, A Andriani, Enrico Montefusco, Giuseppe Cimino, Giuliana Alimena, Roberto Latagliata, Nicoletta Villivà, Michele Cedrone, Sabrina Crescenzi Leonetti, Cinzia De Gregoris, Marianna De Muro, Cristina Santoro
Publikováno v:
American Journal of Hematology. 89:542-546
To identify prognostic factors affecting thrombosis-free survival (TFS) and overall survival (OS), we report the experience of a Regional cooperative group in a real-life cohort of 1,144 patients with essential thrombocythemia (ET) diagnosed from Jan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89ac449093ea607f426c180f70f02473
https://doi.org/10.1002/ajh.23685
https://doi.org/10.1002/ajh.23685
Autor:
Stefano Mancini, D. De Benedittis, Alessia Campagna, M.A. Aloe Spiriti, Massimo Breccia, Roberto Latagliata, Francesco Buccisano, Annalina Piccioni, Luana Fianchi, Sara Mohamed, Mita Mancini, Susanna Fenu, Pasquale Niscola, Agostino Tafuri, Marianna Criscuolo, Ida Carmosino, A Di Veroli, Nicoletta Villivà
Publikováno v:
HemaSphere. 3:613
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b3fdbc18e507f7df4358d6ecf019c277
https://doi.org/10.1097/01.hs9.0000563652.68531.d6
https://doi.org/10.1097/01.hs9.0000563652.68531.d6
Autor:
Francesca Cristofari, Angelo Zullo, Cesare Hassan, Claudia Iegri, Nicoletta Villivà, Alessandro Andriani, Sergio Morini
Publikováno v:
Italian Journal of Medicine, Vol 4, Iss 3, Pp 154-158 (2013)
The incidence of primary gastric lymphoma in Italy is considerably higher than that observed in the rest of Europe. It is widely accepted that gastric B-cell, low-grade mucosalassociated lymphoid tissue (MALT) lymphoma is caused by specific host-bact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b562cf1f92524749205fcf17f28949e1
http://www.italjmed.org/index.php/ijm/article/view/201
http://www.italjmed.org/index.php/ijm/article/view/201
Autor:
Elisabetta Abruzzese, Antonio Spadea, Barbara Anaclerico, Marco Montanaro, Malgorzata Monica Trawinska, Matteo Molica, Nicoletta Villivà, Gioia Colafigli, Ambra Di Veroli, Antonietta Centra, Michele Cedrone, Luca Petriccione, Roberto Latagliata, Fulvio Massaro, Francesca Celesti, Massimo Breccia, Francesco Buccisano, Alessandro Andriani, Giuseppe Cimino
Publikováno v:
Annals of hematology. 96(3)
Ruxolitinib, a JAK1 and JAK2 inhibitor, has been tested and approved for the treatment of primary and secondary myelofibrosis (MF). Aim of our study is to report safety and efficacy of ruxolitinib in 98 patients affected by MF treated outside clinica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50edaa8edfd546e44b58e6d660b172c2
https://pubmed.ncbi.nlm.nih.gov/27889820
https://pubmed.ncbi.nlm.nih.gov/27889820